The role of the miR-31/FIH1 pathway in TGF-β-induced liver fibrosis

Clinical Science

Volumn 129, Issue 4, 2015, Pages 305-317

  Hu, Jiangfeng ^a,b   Chen, Chao ^c   Liu, Qidong ^d   Liu, Baohai ^e   Song, Chenlin ^f   Zhu, Songchen ^d   Wu, Chaoqun ^g   Liu, Su ^a   Yu, Hongyu ^a   Yao, Dingkang ^a   Kang, Jiuhong ^d   Zhu, Liang ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b TONGJI HOSPITAL OF TONGJI UNIVERSITY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

^d TONGJI UNIVERSITY   (China)

^e SECOND MILITARY MEDICAL UNIVERSITY   (China)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g FUDAN UNIVERSITY   (China)

Author keywords

Fibrogenesis; Hepatic stellate cells; miRNAs; Smad

Indexed keywords

GELATINASE A; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MICRORNA 31; PLATELET DERIVED GROWTH FACTOR BB; SHORT HAIRPIN RNA; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; 3' UNTRANSLATED REGION; FACTOR INHIBITING HYPOXIA-INDUCIBLE FACTOR 1, MOUSE; HIF1AN PROTEIN, HUMAN; MICRORNA; MIRN31 MICRORNA, HUMAN; MIRN31 MICRORNA, MOUSE; MIRN31 MICRORNA, RAT; MIXED FUNCTION OXIDASE; REPRESSOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL MIGRATION; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROGENESIS; FIH1 GENE; GENE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; LUCIFERASE ASSAY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; STELLATE CELL; UPREGULATION; 3' UNTRANSLATED REGION; ANIMAL; BINDING SITE; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; EXPERIMENTAL LIVER CIRRHOSIS; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; LIVER; METABOLISM; PATHOLOGY; REPORTER GENE; RNA INTERFERENCE;

3' UNTRANSLATED REGIONS; ANIMALS; BINDING SITES; CELL MOVEMENT; CELL PROLIFERATION; GENES, REPORTER; HEK293 CELLS; HEPATIC STELLATE CELLS; HUMANS; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MATRIX METALLOPROTEINASE 2; MICE; MICRORNAS; MIXED FUNCTION OXYGENASES; RATS; REPRESSOR PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 84938497226     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20140012     Document Type: Article

References (39)

1. Bataller, R. and Brenner, D.A. (2005) Liver fibrosis. J. Clin. Invest. 115, 209-218.
2. Geerts, A. (2001) History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin. Liver Dis. 21, 311-335.
3. Gressner, A.M. and Weiskirchen, R. (2006) Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. J. Cell. Mol. Med. 10, 76-99.
4. Derynck, R. and Zhang, Y.E. (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425, 577-584.
5. Ambros, V. (2004) The functions of animal microRNAs. Nature 431, 350-355.
6. He, L. and Hannon, G.J. (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5, 522-531.
7. Esquela-Kerscher, A. and Slack, F.J. (2006) Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 6, 259-269.
8. Szabo, G. and Bala, S. (2013) MicroRNAs in liver disease. Nat. Rev. Gastroenterol. Hepatol. 10, 542-552.
9. Wang, X.W., Heegaard, N.H. and Orum, H. (2012) MicroRNAs in liver disease. Gastroenterology 142, 1431-1443.
10. Ogawa, T., Enomoto, M., Fujii, H., Sekiya, Y., Yoshizato, K., Ikeda, K. and Kawada, N. (2012) MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis. Gut 61, 1600-1609.
11. Iizuka, M., Ogawa, T., Enomoto, M., Motoyama, H., Yoshizato, K., Ikeda, K. and Kawada, N. (2012) Induction of microRNA-214-5p in human and rodent liver fibrosis. Fibrogenesis Tissue Repair 5, 12.
12. Venugopal, S.K., Jiang, J., Kim, T.H., Li, Y., Wang, S.S., Torok, N.J., Wu, J. and Zern, M.A. (2010) Liver fibrosis causes downregulation of miRNA-150 and miRNA-194 in hepatic stellate cells, and their overexpression causes decreased stellate cell activation. Am. J. Physiol. Gastrointest. Liver Physiol. 298, G101-G106.
13. Sekiya, Y., Ogawa, T., Iizuka, M., Yoshizato, K., Ikeda, K and Kawada, N. (2011) Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-beta-induced inhibition of hepatic stellate cell proliferation. J. Cell. Physiol. 226, 2535-2542.
14. Ji, J., Zhang, J., Huang, G., Qian, J., Wang, X. and Mei, S. (2009) Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation. FEBS Lett. 583, 759-766.
15. Dong, Z., Zhong, Z., Yang, L., Wang, S. and Gong, Z. (2014) MicroRNA-31 inhibits cisplatin-induced apoptosis in non-small cell lung cancer cells by regulating the drug transporter ABCB9. Cancer Lett. 343, 249-257.
16. Zhang, T., Wang, Q., Zhao, D., Cui, Y., Cao, B., Guo, L. and Lu, S.H. (2011) The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. Clin. Sci. 121, 437-447.
17. Liu, C.J., Lin, S.C., Yang, C.C., Cheng, H.W. and Chang, K.W. (2012) Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma. Head Neck 34, 219-224.
18. Siow, M.Y., Ng, L.P., Chong, V.K., Jamaludin, M., Abraham, M.T., Abdul Rahman, Z.A., Kallarakkal, T.G., Yang, Y.H., Cheong, S.C. and Zain, R. B (2014) Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma. Oral Dis. 20, 345-351.
19. Friedman, S.L. and Roll, F.J. (1987) Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan. Anal. Biochem. 161, 207-218.
20. Friedman, S.L., Rockey, D.C., McGuire, R.F., Maher, J.J., Boyles, J.K. and Yamasaki, G. (1992) Isolated hepatic lipocytes and Kupffer cells from normal human liver: morphological and functional characteristics in primary culture. Hepatology 15, 234-243.
21. Chen, C., Wu, C.Q., Zhang, Z.Q., Yao, D.K. and Zhu, L. (2011) Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation. Exp. Cell Res. 317, 1714-1725.
22. Vogel, S., Piantedosi, R., Frank, J., Lalazar, A., Rockey, D.C., Friedman, S.L. and Blaner, W.S. (2000) An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J. Lipid. Res. 41, 882-893.
23. Yang, C., Zeisberg, M., Mosterman, B., Sudhakar, A., Yerramalla, U. and Holthaus, K. (2003) Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology 124, 147-159.
24. Friedman, S.L. (1997) Molecular mechanisms of hepatic fibrosis and principles of therapy. J. Gastroenterol. 32, 424-430.
25. Roderburg, C., Luedde, M., Vargas Cardenas, D., Vucur, M., Mollnow, T., Zimmermann, H.W., Koch, A., Hellerbrand, C., Weiskirchen, R., Frey, N. et al. (2013) miR-133a mediates TGF-beta-dependent derepression of collagen synthesis in hepatic stellate cells during liver fibrosis. J. Hepatol. 58, 736-742.
26. Yang, S., Xie, N., Cui, H., Banerjee, S., Abraham, E., Thannickal, V.J. and Liu, G. (2012) miR-31 is a negative regulator of fibrogenesis and pulmonary fibrosis. FASEB J. 26, 3790-3799.
27. Masamune, A., Nakano, E., Hamada, S., Takikawa, T., Yoshida, N. and Shimosegawa, T. (2014) Alteration of the microRNA expression profile during the activation of pancreatic stellate cells. Scand. J. Gastroenterol. 49, 323-331.
28. Mahon, P.C., Hirota, K. and Semenza, G.L. (2001) FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 15, 2675-2686.
29. Jiang, B.H., Rue, E., Wang, G.L., Roe, R. and Semenza, G.L. (1996) Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271, 17771-17778.
30. 2 tension. Am. J. Physiol. 271, C1172-C1180.
31. Jiang, B.H., Zheng, J.Z., Leung, S.W., Roe, R. and Semenza, G.L. (1997) Transactivation and inhibitory domains of hypoxia-inducible factor 1alpha. Modulation of transcriptional activity by oxygen tension. J. Biol. Chem. 272, 19253-19260.
32. Liu, C., Gaca, M.D., Swenson, E.S., Vellucci, V.F., Reiss, M. and Wells, R.G. (2003) Smads 2 and 3 are differentially activated by transforming growth factor-beta (TGF-beta) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-beta-independent. J. Biol. Chem. 278, 11721-11728.
33. Uemura, M., Swenson, E.S., Gaca, M.D., Giordano, F.J., Reiss, M. and Wells, R.G. (2005) Smad2 and Smad3 play different roles in rat hepatic stellate cell function and alpha-smooth muscle actin organization. Mol. Biol. Cell. 16, 4214-4224.
34. Schnabl, B., Kweon, Y.O., Frederick, J.P., Wang, X.F., Rippe, R.A. and Brenner, D.A. (2001) The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology 34, 89-100.
35. Zhong, X., Chung, A.C., Chen, H.Y., Meng, X.M. and Lan, H.Y. (2011) Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J. Am. Soc. Nephrol. 22, 1668-1681.
36. Chung, A.C., Huang, X.R., Meng, X. and Lan, H.Y. (2010) miR-192 mediates TGF-beta/Smad3-driven renal fibrosis. J. Am. Soc. Nephrol. 21, 1317-1325.
37. Janssen, H.L., Reesink, H.W., Lawitz, E.J., Zeuzem, S., Rodriguez-Torres, M., Patel, K., van der Meer, A.J., Patick, A.K., Chen, A., Zhou, Y. et al. (2013) Treatment of HCV infection by targeting microRNA. N. Engl. J. Med. 368, 1685-1694.
38. Karakikes, I., Chaanine, A.H., Kang, S., Mukete, B.N., Jeong, D., Zhang, S., Hajjar, R.J. and Lebeche, D. (2013) Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling. J. Am. Heart Assoc. 2, e000078.
39. Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S. et al. (2008) MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456, 980-984.